Daiken Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 7, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	14,985	10,860	-	-
Enterprise Value	9,942	9,874	-	-
Last Close Price	18.50	17.34	-	-
PE Ratio	42.35	101.90	-	-
PS Ratio	8.41	7.97	-	-
PB Ratio	2.80	8.31	-	-
P/TBV Ratio	2.80	8.33	-	-
P/FCF Ratio	50.77	215.06	-	-
P/OCF Ratio	50.67	209.86	-	-
EV/Sales Ratio	5.58	7.25	-	-
EV/EBITDA Ratio	35.60	64.48	-	-
EV/EBIT Ratio	36.43	66.31	-	-
EV/FCF Ratio	33.68	195.53	-	-
Debt / Equity Ratio	0.00	0.00	1.12	0.60
Debt / EBITDA Ratio	0.07	0.01	1.35	1.21
Debt / FCF Ratio	0.07	0.05	2.63	3.27
Asset Turnover	0.48	1.19	1.87	-
Inventory Turnover	1.78	1.99	1.71	-
Quick Ratio	17.91	5.36	0.80	1.23
Current Ratio	19.43	6.56	1.64	2.17
Return on Equity (ROE)	8.09%	13.71%	67.55%	-
Return on Assets (ROA)	4.63%	8.15%	20.01%	-
Return on Capital (ROIC)	4.91%	10.15%	28.76%	-
Return on Capital Employed (ROCE)	5.10%	11.40%	68.80%	38.90%
Earnings Yield	1.79%	0.98%	-	-
FCF Yield	1.97%	0.46%	-	-
Dividend Yield	2.97%	2.33%	-	-
Payout Ratio	193.78%	2.89%	87.59%	-
Buyback Yield / Dilution	-77.82%	-95.20%	-44.34%	-
Total Shareholder Return	-74.85%	-92.87%	-44.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.